| 2002 |
PCLO encodes Piccolo, a presynaptic cytoskeletal protein containing distinct homology domains, and comparison with Bassoon (a structurally related active zone protein) shows only subsets of domains are shared, indicating Piccolo and Bassoon perform related but distinct functions at presynaptic active zones as sites of neurotransmitter release. |
cDNA cloning, amino acid sequence comparison across human, mouse, rat, and chicken; gene structure characterization (25 coding exons over 380 kb) |
International journal of developmental neuroscience |
Medium |
12175852
|
| 2013 |
The intronic SNP rs13438494 (C allele) in PCLO intron 24 reduces splicing efficiency of the PCLO minigene, acting by creating or disrupting splicing regulatory motifs (enhancer/silencer binding sites). |
Minigene splicing assay with A and C alleles; bioinformatics prediction of splicing regulatory sequences (Human Splice Finder) |
PloS one |
Medium |
24167553
|
| 2015 |
The PCLO p.Ser4814Ala (rs2522833) variant, located near a calcium-sensing domain of Piccolo, increases synaptic Piccolo protein levels and produces ~30% increased excitatory synaptic transmission in cultured neurons; however, calcium-dependent phospholipid binding, synapse formation in vitro, and synaptic accumulation of synaptic vesicles were unaltered by this variant. |
Mouse knock-in model (Pclo-SA/SA), immunostaining for synaptic Piccolo levels, electrophysiology of cultured neurons, calcium-dependent phospholipid binding assay, in vitro synapse formation assay |
Neuroscience |
High |
26045179
|
| 2015 |
A homozygous nonsense mutation in PCLO, predicted to eliminate the PDZ and C2 domains in the C-terminus of the protein, underlies pontocerebellar hypoplasia type 3 (PCH3), establishing that loss of PCLO function is causative for this autosomal recessive neurodegenerative disorder. |
Genome-wide SNP genotyping, linkage analysis, whole-exome sequencing, Sanger sequencing, human fetal brain RNA sequencing |
Neurology |
Medium |
25832664
|
| 2021 |
Rare missense mutations in PCLO (Ser1535Leu and His5142Arg) co-segregate with bipolar disorder and schizophrenia respectively in affected families, implicating PCLO's role in regulating neurotransmission at the presynaptic cytomatrix in these disorders. |
Whole-genome sequencing, family co-segregation analysis, in silico pathogenicity prediction |
Journal of personalized medicine |
Low |
34834409
|
| 2025 |
Piccolo loss of function (PCLO knockout via CRISPR) reduces expression of CtBP1 and BSN (Bassoon), indicating Piccolo regulates expression of other presynaptic cytomatrix genes. |
CRISPR-generated PCLO knockout cell model, real-time PCR for CtBP1 and BSN expression |
Galen medical journal |
Low |
42038819
|
| 2025 |
An astrocyte-specific Piccolo isoform localizes partially at the Golgi; loss of Piccolo (Pclo gene trap rat model) causes fragmented Golgi in astrocytes, impaired secretion of extracellular matrix components Brevican and Tenascin-R, reduced synapse density in co-cultured neurons, and altered intrinsic neuronal network activity (increased mEPSC frequency); these synaptic deficits were rescued by conditioned medium from wild-type astrocytes. |
Pclo gene-trap rat model; RNA-seq; immunohistochemistry/immunocytochemistry for Piccolo isoform, Brevican, Tenascin-R, and GM130 (Golgi marker); neuron-astrocyte co-culture (Banker setup); electrophysiology (RRP, mEPSC, mIPSC); astrocyte-conditioned media rescue experiment |
bioRxivpreprint |
Medium |
|
| 2025 |
Anti-PCLO autoantibodies and PCLO-reactive T-lymphocytes are detected in ARA-positive sarcoid uveitis patients, identifying PCLO as an autoimmune antigenic target in the retina. |
Indirect immunofluorescence for anti-retinal antibodies; HuScan linear epitope mapping; bead-based anti-PCLO antibody assay; ELISpot for PCLO-reactive T-lymphocytes; TCR/BCR repertoire next-generation sequencing |
Journal of autoimmunity |
Medium |
39892202
|